GM’s stock bounces back as revenue grows for the first time in over a year

Daré Bioscience targets Ovaprene top-line data in 2027 as it plans DARE to PLAY dispensing this quarter

Why Coherent Stock Jumped Before Its Own Results Landed

AudioEye expects over $15M run rate adjusted EBITDA by end of 2026 as it raises full-year adjusted EBITDA guidance to at least $12.7M

Jefferson Capital outlines $1.1B expected ERC collections in next 12 months while entering Mexico market